Everand Logo

Welcome to Everand!

  • STAT

    Untangling Trump’s lawyer’s ties to Novartis: Here are 6 unanswered questions

    It’s the glaring omission from Novartis’ statements to date: The Swiss pharma giant says it paid a shell company set up by Trump lawyer and fixer Michael Cohen to discuss…
    by Adam Feuerstein and Damian Garde and Rebecca Robbins May 09, 2018 3 minutes

    Thanks to Novartis, the investigations of President Trump and his minions now have a Big Pharma angle: The drug maker admitted to wiring monthly payments to a company controlled by the president’s lawyer — the same one that paid adult film star Stormy Daniels to keep quiet about an extramarital affair with Trump.

    But in exchange for what? And who thought this was a good idea?

    We have some questions. Here are six.

    1. Why?

    It’s the to discuss “U.S. healthcare policy.”

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
    Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

    Related Books & Audiobooks